ARTICLE | Clinical News
Huvap vapaliximab: Phase I
September 23, 2002 7:00 AM UTC
BTT1V started a U.K. Phase I study of Huvap in 36 healthy volunteers. Huvap was developed in collaboration with Cambridge University and the University of Turku. Boehringer Ingelheim GmbH (Ingelheim,...